Clinicopathological diagnosis of Lennert lymphoma: a case report and review of the literature.

IF 4.6 Q2 MATERIALS SCIENCE, BIOMATERIALS
Shun Ding, Jiao Chen, Jiajun Su, Jiewen Liu, Weihua Yin, Fengjie Qi
{"title":"Clinicopathological diagnosis of Lennert lymphoma: a case report and review of the literature.","authors":"Shun Ding, Jiao Chen, Jiajun Su, Jiewen Liu, Weihua Yin, Fengjie Qi","doi":"10.1186/s13000-024-01533-x","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Lennert lymphoma (LL) is a variant of peripheral T-cell lymphoma, not otherwise specified (PTCL, NOS), also known as a lymphoepithelioid variant of PTCL. Because of the rarity and lack of clear-cut diagnostic criteria, LL is susceptible tomisdiagnosis. Although previously diagnosed with LL might be reclassified and evaluated with the advent of of molecular and/or genetic findings, cytomorphology and immunohistochemistry are still the key to give rise to correct diagnosis.</p><p><strong>Case presentation: </strong>We report a case of a patient who was diagnosed as LL based on cytomorphology and immunohistochemistry. Routine stain (Hematoxlin and Eosin-H&E) revealed tumor cells were mainly small to medium-sized CD4(+) T cells, the CD8 +/TIA-1 + cytotoxic cells were less minority, no expressions of follicle helper T cell markers (CD10, BCL6, PD1, CXCL13, ICOS) or CD21(+) hyperplastic FDC network, or proliferation of high edndothelial venules were noted; however, numerous epithelioid histiocytes are noted in the background and scattered EBV(+) cells were also present. The patient was achieved complete remission after six courses of chemotherapy with cyclophosphamide, epirubicin, vincristine, etoposide, and prednisone regimen. She was followed for 5 years without recurrence or progression.</p><p><strong>Conclusions: </strong>Classic LL is not difficult to diagnose by cytomorphology and immunohistochemistry, and the mutation profiles can be helpful to distinguish LL from other lymphomas.</p>","PeriodicalId":2,"journal":{"name":"ACS Applied Bio Materials","volume":null,"pages":null},"PeriodicalIF":4.6000,"publicationDate":"2024-08-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11328506/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"ACS Applied Bio Materials","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1186/s13000-024-01533-x","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"MATERIALS SCIENCE, BIOMATERIALS","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Lennert lymphoma (LL) is a variant of peripheral T-cell lymphoma, not otherwise specified (PTCL, NOS), also known as a lymphoepithelioid variant of PTCL. Because of the rarity and lack of clear-cut diagnostic criteria, LL is susceptible tomisdiagnosis. Although previously diagnosed with LL might be reclassified and evaluated with the advent of of molecular and/or genetic findings, cytomorphology and immunohistochemistry are still the key to give rise to correct diagnosis.

Case presentation: We report a case of a patient who was diagnosed as LL based on cytomorphology and immunohistochemistry. Routine stain (Hematoxlin and Eosin-H&E) revealed tumor cells were mainly small to medium-sized CD4(+) T cells, the CD8 +/TIA-1 + cytotoxic cells were less minority, no expressions of follicle helper T cell markers (CD10, BCL6, PD1, CXCL13, ICOS) or CD21(+) hyperplastic FDC network, or proliferation of high edndothelial venules were noted; however, numerous epithelioid histiocytes are noted in the background and scattered EBV(+) cells were also present. The patient was achieved complete remission after six courses of chemotherapy with cyclophosphamide, epirubicin, vincristine, etoposide, and prednisone regimen. She was followed for 5 years without recurrence or progression.

Conclusions: Classic LL is not difficult to diagnose by cytomorphology and immunohistochemistry, and the mutation profiles can be helpful to distinguish LL from other lymphomas.

Lennert 淋巴瘤的临床病理诊断:病例报告和文献综述。
背景:伦纳德淋巴瘤(Lennert lymphoma,LL)是外周T细胞淋巴瘤的一种变异型,未另作说明(PTCL,NOS),也称为PTCL的淋巴上皮样变异型。由于 LL 罕见且缺乏明确的诊断标准,因此很容易被误诊。虽然随着分子和/或遗传学发现的出现,以前诊断为LL的患者可能会被重新分类和评估,但细胞形态学和免疫组化仍是正确诊断的关键:我们报告了一例根据细胞形态学和免疫组化确诊为 LL 的患者。常规染色(Hematoxlin and Eosin-H&E)显示肿瘤细胞以中小型 CD4(+)T 细胞为主,CD8 +/TIA-1 + 细胞毒性细胞较少,未见滤泡辅助性 T 细胞标志物(CD10、BCL6、PD1、CXCL13、ICOS)或 CD21(+)增生的 FDC 网络的表达,也未见高密度上皮静脉增生;然而,背景中可见大量上皮样组织细胞,也有散在的 EBV(+)细胞。患者在接受了六个疗程的环磷酰胺、表柔比星、长春新碱、依托泊苷和泼尼松方案化疗后,病情得到完全缓解。随访5年,她的病情没有复发或进展:经典的LL通过细胞形态学和免疫组化诊断并不困难,突变图谱有助于将LL与其他淋巴瘤区分开来。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
ACS Applied Bio Materials
ACS Applied Bio Materials Chemistry-Chemistry (all)
CiteScore
9.40
自引率
2.10%
发文量
464
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信